Autocrine Prostaglandin E2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autocrine Prostaglandin E2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma
Authors
Keywords
Neuroblastoma cells, Neuroblastoma, Immune receptors, Intracellular receptors, Cancer treatment, Inflammation, COX-2 inhibitors, Prostaglandin
Journal
PLoS One
Volume 7, Issue 1, Pages e29331
Publisher
Public Library of Science (PLoS)
Online
2012-01-20
DOI
10.1371/journal.pone.0029331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
- (2011) Hanna Kryh et al. BMC GENOMICS
- Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention
- (2011) S. M. Fischer et al. Cancer Prevention Research
- Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
- (2011) Andrea Koch et al. EUROPEAN JOURNAL OF CANCER
- Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo
- (2011) Lova Segerström et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
- (2010) Rachel S. Midgley et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities
- (2010) Xinrong Ma et al. MOLECULAR CANCER RESEARCH
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EPAC proteins transduce diverse cellular actions of cAMP
- (2009) Gillian Borland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostanoid receptor antagonists: development strategies and therapeutic applications
- (2009) RL Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts
- (2009) Michio Kaneko et al. CANCER SCIENCE
- Protein kinase A as a biological target in cancer therapy
- (2008) Silvio Naviglio et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- AKT pathway in neuroblastoma and its therapeutic implication
- (2008) Hervé Sartelet et al. Expert Review of Anticancer Therapy
- Tumor-growth–promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets
- (2008) Ninib Baryawno et al. NEURO-ONCOLOGY
- Potentiation of PGE2-mediated cAMP production during neuronal differentiation of human neuroblastoma SK-N-BE(2)C cells
- (2003) Se-Young Choi et al. JOURNAL OF NEUROCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started